Biotech company Curis, Inc., a leader in innovative cancer treatments, has announced that as part of a Phase I clinical trial of their new drug CA-170, they’ve enrolled and dosed their first mesothelioma patient. The oral medication targets cancer cells that express high levels of VISTA, a protein understood to help cancer cells resist treatment.…
The post Promising New Mesothelioma Clinical Trial Started This Week appeared first on Mesothelioma.net.
from Mesothelioma.net http://bit.ly/2sUbp9A
via IFTTT
Promising New Mesothelioma Clinical Trial Started This Week
![Promising New Mesothelioma Clinical Trial Started This Week]()
Reviewed by Unknown
on
January 31, 2019
Rating:
No comments: